Catalyst Pharmaceuticals Surges After Report of Potential Acquisition by Angelini Pharma
Catalyst Pharmaceuticals (CPRX) rose 19% following a report that Italian drugmaker Angelini Pharma is considering acquiring the company. The report indicates Angelini is working with advisers to evaluate the potential acquisition.
Topics: M&A Pharmaceuticals Stock Price Movement